824 related articles for article (PubMed ID: 17080284)
1. Anti-Saccharomyces cerevisiae antibody in intestinal Behçet's disease patients: relation to clinical course.
Choi CH; Kim TI; Kim BC; Shin SJ; Lee SK; Kim WH; Kim HS
Dis Colon Rectum; 2006 Dec; 49(12):1849-59. PubMed ID: 17080284
[TBL] [Abstract][Full Text] [Related]
2. Clinical significance of anti-Saccharomyces cerevisiae antibody (ASCA) in Korean patients with Crohn's disease and its relationship to the disease clinical course.
Kim BC; Park S; Han J; Kim JH; Kim TI; Kim WH
Dig Liver Dis; 2007 Jul; 39(7):610-6. PubMed ID: 17531556
[TBL] [Abstract][Full Text] [Related]
3. Differential diagnosis of intestinal Behçet's disease and Crohn's disease by colonoscopic findings.
Lee SK; Kim BK; Kim TI; Kim WH
Endoscopy; 2009 Jan; 41(1):9-16. PubMed ID: 19160153
[TBL] [Abstract][Full Text] [Related]
4. Anti-Saccharomyces cerevisiae and perinuclear anti-neutrophil cytoplasmic antibodies in coeliac disease before and after gluten-free diet.
Granito A; Zauli D; Muratori P; Muratori L; Grassi A; Bortolotti R; Petrolini N; Veronesi L; Gionchetti P; Bianchi FB; Volta U
Aliment Pharmacol Ther; 2005 Apr; 21(7):881-7. PubMed ID: 15801923
[TBL] [Abstract][Full Text] [Related]
5. Antineutrophil cytoplasmic autoantibodies and anti-Saccharomyces cerevisiae antibodies in inflammatory bowel diseases.
Kiliç ZM; Tunç B; Ayaz S; Filik L; Aktaş S; Parlak E; Ulker A
Turk J Gastroenterol; 2004 Dec; 15(4):238-42. PubMed ID: 16249978
[TBL] [Abstract][Full Text] [Related]
6. Conjunctival ulcers in Behçet's disease.
Zamir E; Bodaghi B; Tugal-Tutkun I; See RF; Charlotte F; Wang RC; Wechsler B; LeHoang P; Anteby I; Rao NA
Ophthalmology; 2003 Jun; 110(6):1137-41. PubMed ID: 12799237
[TBL] [Abstract][Full Text] [Related]
7. Surgical treatment of Budd-Chiari syndrome induced by Behcet's disease.
Kuniyoshi Y; Koja K; Miyagi K; Uezu T; Yamashiro S; Arakaki K; Mabuni K; Senaha S
Ann Thorac Cardiovasc Surg; 2002 Dec; 8(6):374-80. PubMed ID: 12517299
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic role of anti-Saccharomyces cerevisiae mannan antibodies combined with antineutrophil cytoplasmic antibodies in patients with inflammatory bowel disease.
Kim BG; Kim YS; Kim JS; Jung HC; Song IS
Dis Colon Rectum; 2002 Aug; 45(8):1062-9. PubMed ID: 12195191
[TBL] [Abstract][Full Text] [Related]
9. Tetanus antitoxin seroprevalence in patients with Behçet's disease.
Ayaslioglu E; Erkek E; Kiliç D; Kaygusuz S; Karaca F; Düzgün N
Scand J Infect Dis; 2003; 35(5):299-301. PubMed ID: 12875513
[TBL] [Abstract][Full Text] [Related]
10. Response to vaccination against hepatitis B in patients with Behcet's disease.
Erkek E; Ayaslioglu E; Erkek AB; Kurtipek GS; Bagci Y
J Gastroenterol Hepatol; 2005 Oct; 20(10):1508-11. PubMed ID: 16174066
[TBL] [Abstract][Full Text] [Related]
11. Behçet's disease.
Krause I; Weinberger A
Curr Opin Rheumatol; 2008 Jan; 20(1):82-7. PubMed ID: 18281862
[TBL] [Abstract][Full Text] [Related]
12. [Comparison of diagnostic criteria in Moroccan patients with Behçet's disease].
El Fajri S; Benchikhi H; Jarmouni R; Lakhdar H
Ann Dermatol Venereol; 2000 Dec; 127(12):1068-72. PubMed ID: 11173681
[TBL] [Abstract][Full Text] [Related]
13. Analysis of clinical course and long-term prognosis of surgical and nonsurgical patients with intestinal Behçet's disease.
Naganuma M; Iwao Y; Inoue N; Hisamatsu T; Imaeda H; Ishii H; Kanai T; Watanabe M; Hibi T
Am J Gastroenterol; 2000 Oct; 95(10):2848-51. PubMed ID: 11051358
[TBL] [Abstract][Full Text] [Related]
14. [Behcet's disease: retrospective study].
Baixauli A; Calvo J; Tamarit JJ; Campos C; García S; Herrera A
An Med Interna; 2001 Aug; 18(8):405-10. PubMed ID: 11589077
[TBL] [Abstract][Full Text] [Related]
15. Prediction of the clinical course of Behçet's colitis according to macroscopic classification by colonoscopy.
Kim JS; Lim SH; Choi IJ; Moon H; Jung HC; Song IS; Kim CY
Endoscopy; 2000 Aug; 32(8):635-40. PubMed ID: 10935793
[TBL] [Abstract][Full Text] [Related]
16. Long-term clinical outcomes and factors predictive of relapse after 5-aminosalicylate or sulfasalazine therapy in patients with intestinal Behcet disease.
Jung YS; Hong SP; Kim TI; Kim WH; Cheon JH
J Clin Gastroenterol; 2012; 46(5):e38-45. PubMed ID: 22298088
[TBL] [Abstract][Full Text] [Related]
17. [Childhood Behçet's disease: clinical and evolutive aspects. About 13 cases].
Laghmari M; Karim A; Allali F; Elmadani A; Ibrahimy W; Hajjaj Hassouni N; Chkili T; Elmalki Tazi A; Mohcine Z
J Fr Ophtalmol; 2002 Nov; 25(9):904-8. PubMed ID: 12515934
[TBL] [Abstract][Full Text] [Related]
18. Caspase-9 expression is increased in endothelial cells of active Behçet's disease patients.
Oztaş P; Lortlar N; Polat M; Alli N; Omeroğlu S; Basman A
Int J Dermatol; 2007 Feb; 46(2):172-6. PubMed ID: 17269970
[TBL] [Abstract][Full Text] [Related]
19. Differentiation of Behcet's disease from inflammatory bowel diseases: anti-Saccharomyces cerevisiae antibody and anti-neutrophilic cytoplasmic antibody.
Filik L; Biyikoglu I
World J Gastroenterol; 2008 Dec; 14(47):7271. PubMed ID: 19084948
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of leptin level and Ob gene polymorphism in patients with Behcet's disease.
Okudan N; Acar H; Gökbel H; Mevlitoğlu I; Sari F
Arch Dermatol Res; 2006 Aug; 298(3):127-30. PubMed ID: 16786343
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
